XML 19 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   112,639,146    
Beginning balance at Dec. 31, 2023 $ 482,597,000 $ 113,000 $ 1,267,469,000 $ (784,985,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (61,343,000)     (61,343,000)
Exercise of stock options (in shares) 1,507,226 1,507,226    
Exercise of stock options $ 9,704,000 $ 3,000 9,701,000  
Issuance of common stock related to Spyce milestone achievement $ 2,132,000      
Issuance of common stock related to Spyce milestone achievement (in shares)   208,042    
Issuance of common stock related to restricted shares (in shares)   369,355    
Stock Issued During Period, Shares, Performance Stock Awards, Gross 900,000      
Shares repurchased for employee tax withholding (in shares)   (281)    
Shares repurchased for employee tax withholding $ 0   0  
Stock-based compensation expense 30,214,000   30,214,000  
Ending balance (in shares) at Sep. 29, 2024   115,623,488    
Ending balance at Sep. 29, 2024 463,304,000 $ 116,000 1,309,516,000 (846,328,000)
Beginning balance (in shares) at Jun. 30, 2024   114,139,532    
Beginning balance at Jun. 30, 2024 470,135,000 $ 114,000 1,295,533,000 (825,512,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (20,816,000)     (20,816,000)
Exercise of stock options (in shares)   479,042    
Exercise of stock options $ 4,300,000 $ 2,000 4,298,000  
Issuance of common stock related to restricted shares (in shares)   105,009    
Stock Issued During Period, Shares, Performance Stock Awards, Gross 900,000      
Shares repurchased for employee tax withholding (in shares) (95)      
Shares repurchased for employee tax withholding $ 0      
Stock-based compensation expense 9,685,000   9,685,000  
Ending balance (in shares) at Sep. 29, 2024   115,623,488    
Ending balance at Sep. 29, 2024 463,304,000 $ 116,000 1,309,516,000 (846,328,000)
Beginning balance (in shares) at Dec. 29, 2024   117,116,311    
Beginning balance at Dec. 29, 2024 446,145,000 $ 117,000 1,321,386,000 (875,358,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (84,343,000)     (84,343,000)
Exercise of stock options (in shares) 380,345 380,345    
Exercise of stock options $ 3,014,000 $ 1,000 3,013,000  
Issuance of common stock related to Spyce milestone achievement 4,709,000      
Issuance of common stock related to Spyce milestone achievement (in shares)   242,722    
Issuance of common stock related to restricted shares (in shares)   639,522    
Shares repurchased for employee tax withholding (in shares)   (9,859)    
Shares repurchased for employee tax withholding (261,000)   (261,000)  
Stock-based compensation expense 24,032,000   24,032,000  
Ending balance (in shares) at Sep. 28, 2025   118,369,041    
Ending balance at Sep. 28, 2025 393,296,000 $ 118,000 1,352,879,000 (959,701,000)
Beginning balance (in shares) at Jun. 29, 2025   118,197,505    
Beginning balance at Jun. 29, 2025 423,298,000 $ 118,000 1,346,735,000 (923,555,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (36,146,000)     (36,146,000)
Exercise of stock options (in shares)   56,976    
Exercise of stock options 335,000   335,000  
Issuance of common stock related to restricted shares (in shares)   114,674    
Shares repurchased for employee tax withholding (in shares)   (114)    
Shares repurchased for employee tax withholding (2,000)   (2,000)  
Stock-based compensation expense 5,811,000   5,811,000  
Ending balance (in shares) at Sep. 28, 2025   118,369,041    
Ending balance at Sep. 28, 2025 $ 393,296,000 $ 118,000 $ 1,352,879,000 $ (959,701,000)